A study evaluated the effect of ABCB1 silencing, and verapamil and CBT1 (an ABC transporter inhibitor) showed similar activities under both conditions, with the gene-silenced condition being slightly more effective in overcoming drug resistance in osteosarcoma [64]. The gene discussed is ABCB1; the disease is osteosarcoma.